Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
XNPT > SEC Filings for XNPT > Form 8-K on 26-Sep-2013All Recent SEC Filings

Show all filings for XENOPORT INC

Form 8-K for XENOPORT INC


26-Sep-2013

Entry into a Material Definitive Agreement


Item 1.01 Entry into a Material Definitive Agreement.

On September 25, 2013, XenoPort, Inc. (the "Company") entered into a Master Manufacturing and Supply Agreement (the "Supply Agreement") with Patheon Pharmaceuticals Inc. ("Patheon") pursuant to which Patheon agreed to supply the Company with commercial supplies of Horizant (gabapentin enacarbil) Extended-Release Tablets (the "Product"). Patheon is currently qualified by the U.S. Food and Drug Administration to manufacture and supply the Product and has served as a contract manufacturer of the Product for Glaxo Group Limited. Under the Supply Agreement, the Company will provide non-binding rolling forecasts to Patheon of its long-term requirements for the Product, and from time-to-time deliver binding firm purchase orders for manufacturing and supply of the Product. The Company will be responsible for providing Patheon with the active pharmaceutical ingredient in the Product. The Company's purchase price for the manufacture and supply of the Product from Patheon is volume-based. The Company is not subject to any minimum purchase requirements under the Supply Agreement, and may purchase its requirements of the Product from any other qualified suppliers. During the term of the Supply Agreement, Patheon is not permitted to manufacture gabapentin enacarbil (or any product containing gabapentin enacarbil) for any party other than the Company, its designee or any authorized licensee of the Company. The Supply Agreement commenced on September 25, 2013 and expires on December 31, 2025, and thereafter will automatically renew for one-year periods unless either party provides 18 months prior notice of its desire not to renew. In addition, the Company may terminate the Supply Agreement for any reason upon 18 months prior notice, and both parties have early termination rights with notice of varying lengths for other causes, including for the counterparty's uncured breach. Patheon also has the right to terminate the Supply Agreement upon 18 months prior notice if the Company sells, assigns or otherwise transfers rights to Horizantto a competitor of Patheon.

The foregoing is only a brief description of the material terms of the Supply Agreement, does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the Supply Agreement, which will be filed as an exhibit to the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2013.


  Add XNPT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for XNPT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.